News Conference News TCT 2018 ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year Lucy Hicks September 24, 2018
News Conference News TCT 2018 REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR Yael L. Maxwell September 23, 2018
News Conference News ESC 2018 Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy Michael O'Riordan August 27, 2018
News Conference News The Structural Heart Disease Summit 2018 High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense? Michael O'Riordan June 22, 2018
News Conference News EuroPCR 2018 DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis Caitlin E. Cox May 30, 2018
News Conference News EuroPCR 2018 New Bioresorbable Scaffold, Magmaris, Delivers Positive Early Outcomes Michael O'Riordan May 25, 2018
News Conference News EuroPCR 2018 NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years Caitlin E. Cox May 24, 2018
News Conference News EuroPCR 2018 New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement Shelley Wood May 22, 2018
News Conference News EAS 2018 Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction Yael L. Maxwell May 08, 2018
News Conference News CANVAS Analysis Provides Heart Failure Reassurances for Canagliflozin Michael O'Riordan March 16, 2018
News Conference News CRT 2018 Ticagrelor: Better Platelet Blockade Post-TAVR? Michael O'Riordan March 07, 2018
News Conference News CRT 2018 Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better Shelley Wood March 05, 2018
News Conference News CRT 2018 Early Low-Risk TAVR Data Reassure, but Durability Questions Remain Michael O'Riordan March 05, 2018